INS and pancreatic insulinoma: Overexpression of PDE3B in β-cells or insulinoma cells consequently reduces insulin secretion (54,55), whereas genetic down-regulation or pharmacological inhibition of the enzyme amplifies secretion (51,52,56,57), probably by regulating the most distal steps of granule fusion (58).